Genmab A/S reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported sales was USD 896 million compared to USD 715 million a year ago. Net income was USD 53 million compared to USD 195 million a year ago.
Basic earnings per share from continuing operations was USD 0.84 compared to USD 3.06 a year ago. Diluted earnings per share from continuing operations was USD 0.83 compared to USD 3.05 a year ago.




















